News from

Cancer Research

Reset All Filters
401 Results
Home health care—a crucial edge for the future of medicine
nurse helping elderly person cross the street with a walker (On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker.

Home health care—a crucial edge for the future of medicine

Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital.

Jen A. Miller

Why cancers caused by BRCA mutations recur
Gloved hands putting individual tiny pipettes in a holder in a lab setting.

Why cancers caused by BRCA mutations recur

Findings from Penn Medicine uncover possible drivers of recurrent breast and ovarian cancers among women carrying high-risk genetic mutations, pointing to methods to more effectively treat disease.

From Penn Medicine News

A FLASH of radiation may pave the way toward new cancer care for people and pets alike
Meg Ruller with her dog Maple in front of Penn Vet

(Homepage image) Meg Ruller, a 2018 graduate of the School of Veterinary Medicine, calls the FLASH trials “a fantastic opportunity” for Maple to receive a cutting-edge treatment—and to contribute to a scientific understanding of how FLASH radiation might help others in the future.

A FLASH of radiation may pave the way toward new cancer care for people and pets alike

Led by the Perelman School of Medicine’s Keith Cengel and the School of Veterinary Medicine’s Brian Flesner, a new study is evaluating the safety and efficacy of treating oral cancer in dogs with a palliative radiation in just two clinic visits.

Katherine Unger Baillie

NIH-funded canine immunotherapy data center charts a path toward transformative therapies
happy looking golden retriever in a clinic's kennel area

Researchers have learned much from treating dogs like Fantine, a golden retriever owned by Penn Vet supporter Richard Lichter, with immunotherapies for cancer, in part because tumors in dogs can closely resemble those in humans. With new support from the National Institutes of Health, a Penn-led team is ensuring such lessons can effectively translate into new therapeutic approaches. (Image: John Donges/Penn Vet)

NIH-funded canine immunotherapy data center charts a path toward transformative therapies

With support recently granted for five more years, Nicola Mason of the School of Veterinary Medicine and Qi Long of the Perelman School of Medicine hope their work leads to new insights in cancer care for people as well as pets.

Katherine Unger Baillie

Eight Penn scientists receive NIH grants through High-Risk, High-Reward Research program
Eight Penn scientists have received NIH grants through High-Risk, High-Reward Research program. They are pictured left to rigt top to bottom: Perelman School of Medicine’s Bushra Raj, Luca Busino, Donita Brady, Eric Witze, Terence Gade, Amelia Escolano, Chengcheng Jin, and George Burslem.

Eight Penn scientists have received NIH grants through High-Risk, High-Reward Research program. They are pictured left to right, top to bottom: Perelman School of Medicine’s Bushra Raj, Luca Busino, Donita Brady, Eric Witze, Terence Gade, Amelia Escolano, Chengcheng Jin, and George Burslem.

Eight Penn scientists receive NIH grants through High-Risk, High-Reward Research program

A group of five scientists received the Transformative Research Award for a project focusing on cancer research, while three investigators received the New Innovator Award for independent projects developed by early-career investigators.

Brandon Lausch